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Patient education and access of ESRD patients to renal replace-
ment therapies beyond in-center hemodialysis.
Background. Nephrologists report that patients’ choice
should play an important role in the selection of renal replace-
ment therapy (RRT) for end-stage renal disease (ESRD). In the
United States, kidney transplant rates remain low and <10% of
patients utilize home dialysis therapies. This study examined the
effect of pre-ESRD processes on the selection of RRT among
incident ESRD patients.
Methods. Using surveys, data were collected for all patients
admitted to 229 dialysis units in ESRD Network 18 between
April 1, 2002 and May 31, 2002. A total of 1365 patients began
chronic dialysis and 1193 facility (87%) and 428 patient (31%)
surveys were returned.
Results. Substantial proportions of patients were unaware of
their kidney disease (36%) or were not seeing a nephrologist
(36%) until <4 months before first dialysis. The presentation of
treatment options was delayed (48% either after or < 1 month
before the first dialysis). The majority of ESRD patients were
not presented with chronic peritoneal dialysis, home hemodialy-
sis, or renal transplantation as options (66%, 88%, and 74%, re-
spectively). Using multivariate analyses, variables significantly
associated with selection of chronic peritoneal dialysis as dialy-
sis modality were the probability of chronic peritoneal dialysis
being presented as a treatment option and the time spent on
patient education.
Conclusion. An incomplete presentation of treatment op-
tions is an important reason for under-utilization of home dial-
ysis therapies and probably delays access to transplantation.
Improvements in and reimbursement for pre-ESRD education
could provide an equal and timely access for all medically suit-
able patients to various RRTs.
Among the various therapies for end-stage renal dis-
ease (ESRD), renal transplantation is associated with
the greatest longevity and the highest quality of life [1].
Even though the best outcomes are reported in patients
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transplanted before the need for maintenance dialysis
(“preemptive”), the limited availability of organ donors
requires that even medically suitable patients undergo
maintenance dialysis for prolonged periods [2–5]. In the
United States, over 90% of patients undergo in-center
maintenance hemodialysis; chronic peritoneal dialysis is
the dominant home dialysis therapy. Several studies have
recently reported the demographic, clinical, and pre-
ESRD care variables associated with the selection of a
home dialysis therapy in the United States [6–8]. Not
withstanding these associations, nephrologists report that
patient choice should be given primacy in selecting a dial-
ysis therapy [9].
There are wide variations in the relative use of chronic
peritoneal dialysis for the treatment of ESRD across the
18 ESRD networks in the United States [10]. There ap-
pear to be tremendous opportunities to improve the pro-
cess of modality selection—specifically, 75% of patients
commencing maintenance hemodialysis report that they
were not offered chronic peritoneal dialysis as a treat-
ment option [11, 12]. However, the importance of vari-
ables relating to pre-ESRD education in the selection of
the dialysis modality has not been previously studied.
The ESRD Network 18 has undertaken a Continu-
ous Quality Improvement Project to ensure an equal ac-
cess of renal replacement therapies (RRTs) to patients
commencing maintenance dialysis in Southern Califor-
nia [13]. As a first step, data were collected about the
steps involved in modality selection (diagnosis of chronic
kidney disease, referral to nephrologists, and pre-ESRD
patient education). The data thus collected were analyzed
to test the hypothesis that pre-ESRD education is associ-
ated with a higher probability of selecting a home dialysis
modality.
METHODS
Study design
Data were collected for all incident patients admit-
ted to dialysis units located in ESRD Network 18
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between April 1, 2002 and May 31, 2002. Three instru-
ments were used for data collection: Centers for Med-
icaid and Medicare Services (CMS) Medical Evidence
Form 2728 (“form 2728”), a form to be completed by
the personnel at the dialysis facilities (“facility survey”),
and a survey to be completed by the patients (“patient
survey”—English and Spanish) (the English version is
shown as Fig. 1).
A pilot survey was administered to ten incident ESRD
patients and the results were used to finalize the study
instruments. During the third week of March, instruc-
tions were mailed to all the dialysis units (N = 229) lo-
cated in the Network. The dialysis unit personnel were
asked to complete a facility survey for every eligible pa-
tient for whom a form 2728 was to be filed with the
Network. The units were also advised to provide all the
patients with a copy of the patient survey along with a
cover letter that explained the purpose of the survey and
a prestamped envelope. The letter encouraged them to
complete the survey but clarified that their participation
was voluntary and confidential. Periodic reminders were
sent to each of the 229 dialysis units through July 2002.
Monthly tracking was performed wherein the response
rate of each dialysis unit to the study surveys was com-
pared to the form 2728s submitted for the period—in
the case of discrepancy, delinquency notices were faxed
several times to individual dialysis units, through July
2002.
The study protocol and questionnaires were reviewed
and approved by the CMS Regional Office and the In-
stitutional Review Board and the Research Committee
at the Los Angeles Biomedical Research Institute at
Harbor-UCLA Medical Center.
Statistical analyses
Continuous variables are expressed as mean and 95%
CIs of mean. In 310 (23%) patients, the laboratory data
on the form 2728 was obtained after the first dialysis treat-
ment. These data on blood urea nitrogen (BUN), serum
creatinine, and glomerular filtration rate (GFR) were ex-
cluded. Patients undergoing any form of peritoneal dial-
ysis, or had already undergone surgery to have a chronic
peritoneal dialysis catheter placed were classified as un-
dergoing chronic peritoneal dialysis.
Analyses were performed using statistical software
packages (SPSS, Inc., Chicago, IL, USA, version 8.2)
(SAS Inc., Cary, NC, USA). Pearson’s chi-square tests
were used to compare the frequency data and associa-
tions were judged with Cramer’s V, a type of correlation
coefficient suitable for categorical data. In particular,
Cramer’s V is a measure of correlation (association) de-
rived from the Pearson chi-square. Similar to the usual
Pearson correlation coefficient for continuous variables,
Cramer’s V ranges in value from −1 to +1 for 2 × 2 ta-
bles and from 0 to 1 for more general tables. The closer
the value is to 1 the more highly correlated the cate-
gorical responses are to one another. To determine the
difference between various continuous variables, student
t test and analyses of variance (ANOVA) were used, as
appropriate.
Factors associated with the likelihood of using chronic
peritoneal dialysis versus maintenance hemodialysis
were determined using multiple logistic regression with
adjustments for baseline demographics, comorbidity, and
laboratory values as recorded in the CMS Medical Evi-
dence Form 2728. Because of the small number of patients
with complete laboratory values on albumin, BUN, cre-
atinine, and GFR, two separate logistic regressions were
performed. The first model includes albumin, BUN, cre-
atinine, and GFR as predictors of modality selection but
excludes comorbidity assessed by the inability to ambu-
late or transfer because the data were too sparse to in-
corporate this factor. This analysis is based on a subset of
753 patients. The second model excludes albumin, BUN,
creatinine, and GFR as predictors, and it combines the in-
ability to ambulate or transfer into one comorbid event.
This model utilizes data from 1322 patients and provides
a more robust analysis of predictors of modality selection
given the larger sample size. These models were used to
determine possible confounding factors that should be
controlled for in subsequent analyses examining the re-
lationship between modality selection and specific items
in the patient survey.
Following this initial analysis, a second set of logistic re-
gression models were fit to patient survey data obtained
from a subset of 327 patients. In this analysis, separate
logistic regression models were carried out to determine,
individually, whether the length of time patients’ knew
about kidney failure, the timing of referral to a nephrolo-
gist, the timing of the presentation of treatment options,
whether chronic peritoneal dialysis was presented as a
treatment option, and the length of time spent discussing
treatment options were associated with modality selec-
tion. In each case, the analysis was adjusted for the ef-
fects of six baseline covariates: age, primary diagnosis,
cardiovascular comorbidity (presence of congestive heart
failure, ischemic heart disease, myocardial infarction, or
other cardiovascular events), employment status, use of
erythropoietin (EPO), and plasma hemoglobin (g/dL) as
these factors had been identified in our initial analyses
as being significantly or nearly significantly (P < 0.10)
associated with modality selection. Results from these
separate models identified presentation of chronic peri-
toneal dialysis as a treatment option and the amount of
time spent discussing treatment options as being signif-
icantly associated with modality selection. Because the
models were all consistent with respect to the effects the
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Fig. 1. Modality selection project patient survey.
six baseline covariates had on modality selection, we also
fit a single multivariate logistic regression model that in-
cluded the six baseline covariates and the five patient sur-
vey questions. Results of the individual models and joint
model are presented together. Specifically, we report re-
sults based on the single multivariate logistic model in
order to gauge what effects patient therapy education
and treatment options have on the previously identified
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Fig. 1. (continued.)
associations between modality selection and age, car-
diovascular disease, employment status, EPO use,
hemoglobin levels, and cause of ESRD. We also include
estimated odds ratios and P values for the five patient
survey items based on the individual logistic regression
models because the joint model, although qualitatively
consistent with the individual models, did result in in-
flated standard errors related to issues of multicollinear-
ity and/or sparse data. In all cases, a P value of < 0.05 was
considered statistically significant.
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Table 1. A comparison of the characteristics of all incident patients for the period of the study to the subset of respondents to the patient survey
for whom data could be linked to Form 2728
Facility survey Subset of respondents to patient survey
Incident cohort responders (N = 428)
Number of patients 1365 1193 327
Age yearsa 63.7 (62.8, 64.6) 64.1 (63.2, 65.0) 62.7 (61.0, 64.4)
Gender (male/female)% 53/47 53/47 53/47
Race%
White 73.3 74.1 75.8
Black 13.9 13.8 12.2
Asian 8.7 8.5 7.3
Other 4.2 3.6 4.6
Hispanic ethnicity%
Hispanic 36.9 36.7 35.5
Non-Hispanic 63.1 63.3 64.5
Current employment status%b
Unemployed 24.2 23.6 20.5
Employed 7.5 7.6 9.8
Homemaker 6.5 7.0 7.3
Retired 55.2 55.7 55.7
Other/unspecified 6.7 6.0 6.7
Primary cause of renal failure%
Diabetes 47.1 48.3 42.8
Hypertension 29.4 28.5 30.8
Others 23.5 23.2 26.3
Comorbid conditions%
Congestive heart failure 29.1 29.3 21.7
Ischemic heart disease 17.4 17.7 15.6
Myocardial Infarction 7.2 7.3 6.4
Other cardiovascularc 18.8 18.7 15.9
History of hypertension 78.3 79.1 81.0
Inability to ambulate 4.8 4.4 3.4
Inability to transfer 1.5 1.4 1.2
Height cma 165.4 (164.8, 166.0) 165.4 (164.8, 166.0) 165.9 (164.8, 167.0)
Weight kga 72.1 (71.0, 73.1) 72.6 (71.5, 73.8) 73.0 (70.8, 75.2)
Body mass index kg/m2a 26.3 (25.9, 26.6) 26.5 (26.1, 26.9) 26.4 (25.7, 27.2)
Predialysis erythropoietin% 24.1 25.0 28.1
Hemoglobin g/dLc,d 10.2 (10.0, 10.3) 10.2 (10.1, 10.3) 10.2 (9.9, 10.4)
Serum albumin g/dLa,e 3.1 (3.1, 3.2) 3.1 (3.1, 3.2) 3.2 (3.1, 3.2)
Serum creatinine mg/dLa,f 6.9 (6.7, 7.2) 6.9 (6.6, 7.1) 7.3 (6.8, 7.8)
Estimated glomerular filtration ratea,g,h 10.1 (9.7, 10.5) 10.2 (9.8, 10.6) 9.6 (8.9, 10.3)
Dialysis modality%
In-center hemodialysis 92.8 93.4 93.0
Peritoneal dialysis 7.2 6.6 7.0
aData are expressed as mean and 95% CI for the mean.
bN = 1339, 1171, and 323, respectively.
cPresence of cardiac arrest, dysrhythmia, pericarditis, cerebrovascular disease, odds ratio peripheral vascular disease.
dN = 1327, 1157, and 316, respectively.
eN = 1020, 892, and 238, respectively.
fN = 1055, 928, and 261, respectively.
gGlomerular filtration rate was estimated using the Modification of Diet in Renal Disease (MDRD) equation and expressed as mL/min/1.73 m2.
hN = 1054, 927, and 261, respectively.
RESULTS
Patient characteristics
During the study period, form 2728 was filed for 1365
eligible patients. Facility forms were returned for 1193 pa-
tients (87%) and 428 patients returned the survey (31%).
Of the 428 respondents, 327 (76%) placed identifiers that
permitted us to link their data to their form 2728 or to
the facility survey.
Table 1 summarizes the patient characteristics and
Table 2 summarizes the relative patient characteristics
and adjusted odd ratios of modality selection. Using
model 1, increasing age and body weight and a history of
myocardial infarction were associated with lower odds of
choosing chronic peritoneal dialysis. On the other hand,
“other” employment status (vs. unemployed), increasing
height, higher hemoglobin, or serum albumin were all
associated with higher odds for choosing chronic peri-
toneal dialysis. The data were reanalyzed using model 2
and again, advancing age was associated with lower odds
of choosing chronic peritoneal dialysis. Conversely, com-
pared to unemployed individuals, employed patients and
those with “other/unspecified” employment were associ-
ated with higher odds of choosing chronic peritoneal dial-
ysis. Likewise, predialysis EPO, and higher hemoglobin
were associated with higher odds of choosing chronic
peritoneal dialysis.
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Table 2. Clinical characteristics of patients undergoing maintenance hemodialysis (MHD) and chronic peritoneal dialysis (CPD) in end-stage
renal disease (ESRD) patients
Odds ratioa Odds ratioa
MHD patients CPD Patients Model 1 Model 2
Number of patients 1266 99 753 1322
Age, yearsa,b 64.4 (63.6, 65.3) 54.4 (51.0, 57.7) 0.75 (0.68, 0.97) 0.77 (0.65, 0.91)
Gender%
Male 53.8 47.5 1.00 1.00
Female 46.2 52.5 1.66 (0.74, 3.78) 1.34 (0.77, 2.33)
Race%
White 73.4 71.7 1.00 1.00
Black 13.7 16.2 2.07 (0.80, 5.28) 1.27 (0.60, 2.58)
Asian 8.6 10.1 1.31 (0.33, 4.29) 1.59 (0.64, 2.58)
Other 4.3 2.0 0.47 (0.02,2.79) 0.49 (0.08, 1.81)
Hispanic ethnicity%
Hispanic 36.3 44.4 1.48 (0.69, 3.24) 1.32 (0.74, 2.38)
Non-Hispanic 63.7 55.6 1.00 1.00
Employment status%c
Unemployed 24.6 19.2 1.00 1.00
Employed 6.5 20.2 2.45 (0.90, 6.65) 4.82 (2.26, 10.5)
Homemaker 6.3 8.1 0.52 (0.11, 1.92) 2.13 (0.79, 5.47)
Retired 56.8 35.4 0.54 (0.23, 1.33) 1.51 (0.77, 3.09)
Other/unspecified 5.9 17.2 2.76 (1.04, 7.35) 4.37 (2.00, 9.60)
Primary Cause of ESRD%
Diabetes 46.9 49.5 1.87 (0.82, 4.52) 1.51 (0.84, 2.81)
Hypertension 30.0 21.2 1.09 (0.41, 2.92) 0.99 (0.50, 2.00)
Others 23.1 29.3 1.00 1.00
Comorbid conditions%
Congestive heart failure 30.0 17.2 0.79 (0.35, 1.69) 0.63 (0.33, 1.15)
Ischemic heart disease 17.6 14.1 2.08 (0.80, 5.13) 1.93 (0.89, 3.95)
Myocardial infarction 7.5 3.0 0.14 (0.01, 0.93) 0.32 (0.05, 1.16)
Other cardiovasculard 19.4 11.1 0.73 (0.24, 1.96) 0.80 (0.35, 1.68)
History of hypertension 78.2 79.8 1.61 (0.74, 3.84) 1.19 (0.68, 2.17)
Inability to ambulate 5.1 1.0 — 0.36 (0.02, 1.80)e
Inability to transfer 1.6 0.0 —
Height cmb 165.4 (164.8, 166.0) 164.7 (162.4, 166.9) 2.95 (1.12, 8.83) 1.45 (0.76, 2.84)
Weight kgb 72.1 (71.0, 73.1) 72.1 (68.5, 75.7) 0.57 (0.32, 0.99) 0.83 (0.58, 1.19)
Body mass index kg/m2b 26.3 (25.9, 26.6) 26.4 (25.3, 27.5) 1.34 (0.99, 1.83) 1.10 (0.90, 1.34)
Predialysis erythropoietin% 23.4 33.3 1.77 (0.93, 3.32) 1.86 (1.15, 2.99)
Hemoglobin g/dLb,f 10.1 (10.0, 10.3) 10.7 (10.3, 11.0) 1.16 (1.02, 1.30) 1.10 (1.02, 1.18)
Serum albumin g/dLb,g 3.1 (3.1, 3.2) 3.4 (3.3, 3.6) 2.35 (1.52, 3.70) —
Serum creatinine mg/dLb,h 7.0 (6.7, 7.2) 6.5 (5.9, 7.2) 0.92 (0.75, 1.07) —
Glomerular filtration rateb,i 10.1 (9.7, 10.5) 10.5 (9.3, 11.7) 1.01 (0.91, 1.10) —
Serum urea nitrogen mg/dLb,j 85.8 (83.7, 88.0) 75.7 (70.0, 81.4) 0.95 (0.89, 1.00) —
aOdds ratios: age, per 10-year increase; height, per 10 cm increase; weight, per 5 kg increase; body mass index, per 1 kg/m2 increase; hemoglobin, per 1 g/dL increase;
serum albumin, per 1 g/dL increase; serum creatinine, per 1 mg/dL increase; glomerular filtration rate, per 1 mL/min increase; serum urea nitrogen, per 5 mg/dL.
bData are expressed as mean and 95% CI for the mean.
cHemodialysis, N = 1243; peritoneal dialysis, N = 96.
dPresence of cardiac arrest, dysrhythmia, pericarditis, cerebrovascular disease, odds ratio peripheral vascular disease.
eCombines inability to ambulate or transfer.
fHemodialysis, N = 1233; peritoneal dialysis, N = 94.
gHemodialysis, N = 944; peritoneal dialysis, N = 76.
hHemodialysis, N = 970; peritoneal dialysis, N = 85.
iHemodialysis, N = 969; peritoneal dialysis = 85.
jHemodialysis, N = 955; peritoneal dialysis, N = 84.
Given the borderline significance of some of the indi-
vidual cardiovascular comorbidities, using model 2, we
examined whether there was an association between
overall cardiovascular disease (the presence or absence
of congestive heart failure, ischemic heart disease, my-
ocardial infarction, and other cardiovascular events) and
modality selection. These analyses indicated that patients
with cardiovascular disease were significantly less likely
to start chronic peritoneal dialysis (odds ratio = 0.57,
P = 0.04).
Other than individuals that were wheel-chair/bed
bound, none of the other “perceived relative contraindi-
cations” to chronic peritoneal dialysis was associated with
the selection of chronic peritoneal dialysis (Table 3).
Diagnosis of renal failure and referral to nephrologist
The results of the length of time the patients had known
about their kidney failure (question 1A) and the duration
of predialysis nephrologic care (question 1B) are summa-
rized in Table 4.
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Table 3. Prevalence of relative contraindications to peritoneal dialysis in the patient cohort and their corresponding association (correlation)
with chronic peritoneal dialysis (CPD) being presented as a treatment option and being selected
Percentage of patients with Contraindication Cramer’s V Correlation (P value)
Facility survey Patient survey CPD presented CPD selected
responders responders as option as modality
Relative contraindication (N = 1193) (N = 327) (N = 322) (N = 1193)
Dementia 4.7 4.3 −0.088 (0.11) −0.043 (0.14)
Mental retardation 0.4 0.3 −0.040 (0.47) −0.017 (0.55)
Colostomy/ileostomy 0.4 0.6 0.111 (0.05) −0.017 (0.55)
More than one abdominal surgery 4.6 4.3 0.120 (0.03) 0.006 (0.84)
Blindness 4.8 4.6 −0.002 (0.97) 0.004 (0.90)
Inability to ambulate or transfer 4.4 3.4 −0.135 (0.02) −0.041 (0.15)
Weight >100 kg 8.6 7.6 −0.028 (0.61) 0.014 (0.63)
At least one of the above 24.2 22.9 −0.027 (0.63) −0.025 (0.39)
Wheelchair/bed-bound 20.4 13.8 −0.132 (0.02) −0.085 (0.003)
Data are expressed as percentage of patients in each cohort.
Table 4. Results of patient reports of length of time they knew about
kidney failure and duration of predialysis nephrologic care
“How long were you seeing
“How long have you a nephrologist
known that you have (kidney specialist) before
kidney failure” you started dialysis”
<4 months 36% 36%
4 to 12 months 23% 19%
1 to 3 years 23% 26%
≥3 years 15% 11%
Don’t know/ 3% 8%
remember
The length of time that the patients knew about having
kidney failure was related to the duration of predialysis
nephrologic care (Table 5). However, 25% of patients
who knew of their kidney failure for ≥3 years had been
seeing a nephrologist for ≤1 year and 16% of who had
been seeing a nephrologist for >1 year knew about their
kidney failure for <4 months.
Patient education
Thirty percent of the patients reported that treatment
options were not presented to them until dialysis was
started and 48% reported that the treatment options were
presented either after the first dialysis or<1 month before
the need for first dialysis (Fig. 1, question 2A). There was
a significant relationship between the timing of presenta-
tion of treatment options to the length of time the patient
knew of their kidney failure and the duration of predial-
ysis nephrologic care (Table 5). Among the patients who
reported that dialysis options were not presented to them
until dialysis was started, 28% knew about their kidney
failure for ≥1 year (≥ 4 months, 47%) and 29% had been
seeing a nephrologist for ≥1 year (≥4 months, 42%).
The results of the patients’ report of the renal replace-
ment modalities presented to them at the time of modal-
ity education (Fig. 1, question 2B) are summarized in
Figure 2. Chronic peritoneal dialysis was more likely to be
presented to employed individuals, when compared to the
unemployed, retired, homemaker, or others (employed
58%; other categories 29% to 35%) (P = 0.05). Individu-
als with a history of previous myocardial infarction were
less likely to report that chronic peritoneal dialysis was
offered (P = 0.05); none of the patients who were unable
to ambulate (N = 11) or transfer (N = 4) were presented
with chronic peritoneal dialysis as a treatment option
(Table 3). Paradoxically, those who had more than one ab-
dominal surgery were more likely to be offered chronic
peritoneal dialysis. There was no relationship between
any of the other “perceived relative contraindications” to
chronic peritoneal dialysis to the probability of chronic
peritoneal dialysis being presented as a treatment option
(Table 3). Finally, patients who reported that chronic peri-
toneal dialysis was offered as a treatment modality had a
significantly higher mean plasma hemoglobin at the time
of first dialysis (P = 0.04).
There was no relationship between the length of time
that the patient had known about their kidney failure or
the duration of predialysis nephrologic care to the prob-
ability of offering chronic peritoneal dialysis (Table 5).
The probability of chronic peritoneal dialysis being of-
fered was dependent upon the timing of presentation of
treatment options (Table 5) (patients who reported that
chronic peritoneal dialysis was presented, not until dial-
ysis was started, 28% and ≥1 year, 54%).
No demographic, clinical, laboratory, or pre-ESRD
care variables were associated with the probability of
home hemodialysis being presented as a treatment op-
tion (Table 5).
There was a strong relationship between the pa-
tient’s current employment status and the probability
of transplanation being presented as a treatment op-
tion (employed, 68% compared to 17% to 29% of other
groups) (P < 0.001). There was also a strong relationship
between the primary cause of renal failure and the proba-
bility of transplantation being presented—diabetes mel-
litus, 19%, hypertension, 21%, and other causes, 39%
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Fig. 2. Distribution of responses to the question, “Which of the follow-
ing options were initially offered to you as possible methods of treatment
(“X” all those presented—you may “X” more than one box).”
(P = 0.002). The patients who reported that transplan-
tation was presented as a treatment option were signifi-
cantly younger (P < 0.001), had a significantly lower GFR
(P = 0.02) and a higher serum albumin (P = 0.02). There
was no relationship between the presence of various co-
morbidities and the probability of transplantation being
offered as a treatment option. The probability of trans-
plantation being presented as a treatment option was re-
lated to the length of time that the patient had known
they had kidney failure, the length of time they had been
seeing a nephrologist and the timing of presentation of
treatment options (Table 5).
The results of the patients’ report of the amount of time
spent in discussing treatment options (Fig. 1, question 3B)
are summarized in Figure 3. When asked if the patients
had been provided with enough information regarding
the RRTs (Fig. 1, question 3A), 68% indicated that they
had received more than enough or enough information
and 17% indicated that they received little or no infor-
mation (N = 419). There was no relationship between
satisfaction with information and the length of time that
the patient had known they had kidney failure or had
been seeing a nephrologist (Table 5). On the other hand,
there was a significant relationship between the timing
of presentation of treatment options and the duration of
time spent in modality education to the satisfaction with
the information (Table 5). Finally, patients presented with
either chronic peritoneal dialysis or home hemodialysis
or transplantation reported significantly higher levels of
satisfaction (Table 5).
Impact of the predialysis processes on patient choice
of dialysis modality
Of the 1365 eligible patients in the incident cohort, 1266
were undergoing maintenance hemodialyis (93%) and 99
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Fig. 3. Distribution of responses to the question,“How much time
would you say you spent in total, discussing your treatment options
with a healthcare professional.”
(7%) were undergoing chronic peritoneal dialysis. Only
two patients were undergoing home hemodialysis—thus,
no separate analyses regarding this therapy were per-
formed. Among the 427 patients who completed the pa-
tient survey, 419 reported their current treatment modal-
ity: maintenance hemodialysis, 392 (94%); chronic peri-
toneal dialysis, 24 (6%); and no treatment, 3. There was
a significant relationship between the length of time that
the patient had known about their kidney failure and the
selection of chronic peritoneal dialysis (Table 5). There
was no significant relationship between the duration of
predialysis nephrologic care or the timing of presenta-
tion of options and the current dialysis modality (Table
5). There was a strong relationship between the probabil-
ities of presentation of peritoneal dialysis as a treatment
option to the selection of chronic peritoneal dialysis as
a treatment modality (Table 5). Moreover, there was a
strong relationship between the satisfaction with the in-
formation presented (Cramers’ V, 0.17) (P < 0.05) and
the amount of time spent in discussing treatment options
(Cramers’ V, 0.29) (P < 0.0001) with selecting chronic
peritoneal dialysis.
Multivariate logistic regression analyses were per-
formed to determine the predictors of modality selection
in this cohort (Table 6). Only two variables were signifi-
cantly associated with the selection of chronic peritoneal
dialysis: presentation of chronic peritoneal dialysis as a
treatment option (P, 0.02) and the amount of time spent
in discussing treatment options (P, 0.02).
DISCUSSION
This large scale, comprehensive evaluation of modal-
ity selection brings to fore several novel findings with
regard to modality selection. First, the current status of
pre-ESRD education does not only limit the availabil-
ity of chronic peritoneal dialysis to incident ESRD pa-
tients but also that of home hemodialysis and probably
delays access to transplantation. Second, the failure to
offer chronic peritoneal dialysis is unrelated to the pres-
ence of relative medical contraindications to peritoneal
dialysis and is, only in small part, accounted for by other
pre-ESRD care variables. Finally, variables related to pre-
ESRD education appear to be the most important deter-
minants of selection of home dialysis—the probability of
chronic peritoneal dialysis being offered and the duration
of time spent time in discussing treatment options.
The first cardinal finding of our study is that RRTs other
than maintenance hemodialysis are not offered to most
incident ESRD patients. In our study, 70% of incident
maintenance hemodialysis patients reported that chronic
peritoneal dialysis was not offered as an option for RRT.
These findings are consistent with those from the Dialysis
Morbidity and Mortality Survey (DMMS) Wave 2 study.
They found that 75% of incident maintenance hemodial-
ysis patients (N = 1,782) in the United States reported
that chronic peritoneal dialysis was not discussed as a
treatment option [11]. Even in centers with high rates of
chronic peritoneal dialysis utilization, about 30% of inci-
dent patients with no contra-indications to either main-
tenance hemodialysis or chronic peritoneal dialysis, are
not offered chronic peritoneal dialysis [14, 15]. Thus, it is
reasonable to conclude that our finding of the failure of
health care providers to present chronic peritoneal dialy-
sis as a RRT for most incident ESRD patients represents
the general practice in the United States.
The reasons why chronic peritoneal dialysis is not of-
fered to large proportions of incident ESRD patients has,
heretofore, not been explored. In this study, we sought to
determine if the probability of being offered chronic peri-
toneal dialysis for treatment of ESRD was related to the
presence/absence of relative medical contraindications to
chronic peritoneal dialysis or to the pre-ESRD care. With
regard to former, chronic peritoneal dialysis has been re-
ported to have been successfully performed in most sub-
groups listed in Table 3 [16–19]. Thus, the consideration
of any one of the conditions listed therein as a contraindi-
cation to chronic peritoneal dialysis is likely to vary con-
siderably from physician to physician. The prevalence of
medical contraindications to chronic peritoneal dialysis
in this study (23% to 24%) is similar to the 17% to 21%
prevalence reported from previous single-center studies
from other parts of the world [14, 20, 21]. We were unable
to demonstrate any relationship between the presence of
relative medical contraindications to chronic peritoneal
dialysis and the probability of the therapy being offered.
Thirty-five percent of patients without any of the con-
ditions listed in Table 3 were offered chronic peritoneal
dialysis when compared to 32% of those who had at least
one of those conditions. Thus, it appears unlikely that the
failure to present chronic peritoneal dialysis is related to
the presence of medical contra-indications to the therapy.
We then sought to determine if the failure to offer
chronic peritoneal dialysis was related to the elements
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Table 6. Multivariate logistic regression analyses of the determinants of dialysis modalityaa
Odds Lower Upper Overall
Factor Comparisons ratiob 95% CI 95% CI P value
Age Per 1 year increase 1.00 0.95 1.06 0.99
Cardiovascular comorbidity Present vs. absent 1.01 0.22 4.486 0.999
Erythropoietin use Used vs. not used 0.73 0.17 2.836 0.66
Employment status Employed vs. unemployed 2.68 0.35 23.60 0.61
Homemaker vs. unemployed 1.66 0.06 24.59
Others/unspecified vs. unemployed 0.87 0.03 13.65
Retired vs. unemployed 0.58 0.09 4.31
Hemoglobin Per 1 g/dL increase 0.74 0.45 1.031 0.19
Primary diagnosis Diabetes vs. others 0.53 0.11 2.39 0.55
Hypertension vs. others 1.21 0.28 5.43
Length of time patient knew <4 months vs. >3 years 0.30 (0.22) 0.04 (0.06) 1.97 (0.77) 0.34 (0.11)
about kidney failure 4 to 12 months vs. >3 years 0.76 (0.63) 0.10 (0.18) 5.60 (2.22)
1 to 3 years vs. >3 years 0.18 (0.34) 0.02 (0.07) 1.54 (1.54)
Length of time patient was <4 months vs. >3 years 1.00 (0.32) 0.10 (0.07) 12.72 (1.57) 0.86 (0.17)
seeing a nephrologist 4 to 12 months vs. >3 years 2.07 (1.47) 0.24 (0.36) 20.79 (7.08)
1 to 3 years vs. >3 years 1.54 (0.83) 0.20 (0.20) 12.71 (3.96)
Timing of presentation of Not until dialysis started vs. >1 year 0.60 (0.19) 0.04 (0.03) 7.22 (1.03) 0.52 (0.25)
treatment options <4 months vs. >1 year 1.00 (0.63) 0.15 (0.17) 7.67 (2.70)
4 to 12 months vs. >1 year 0.27 (0.62) 0.03 (0.14) 2.56 (2.87)
Probability of CPD being presented No vs. yes 0.15 (0.07) 0.03 (0.02) 0.63 (0.21) 0.02 (0.0001)
as treatment option
Time spent in presenting <31 minutes vs. >2 hours 0.06 (0.06) 0.01 (0.01) 0.38 (0.28) 0.02 (0.002)
treatment options 31 minutes to 1 hour vs. >2 hours 0.11 (0.12) 0.01 (0.11) 0.70 (0.57)
1 to 2 hours vs. >2 hours 0.44 (0.87) 0.09 (0.25) 1.99 (3.07)
aAdjusted odds ratio, confidence intervals (95% CI) and P values from individual logistic regression models are presented in the parentheses for the five patient
survey questions (see text).
bChronic peritoneal dialysis (CPD) vs. hemodialysis (HD).
related to pre-ESRD care. Again, there were no signif-
icant relationships between the length of times the pa-
tients knew about kidney failure or the duration of pre-
dialysis nephrologic care to the probability of chronic
peritoneal dialysis being discussed. The timing of pre-
sentation of treatment options was the only pre-ESRD
care variable significantly associated with more complete
presentation of treatment modalities. However, even in
the best case scenario (options discussed >1 year before
need for dialysis), only 54% of the patients were offered
chronic peritoneal dialysis as a treatment option.
It follows then that neither the presence of medical
contraindications to the therapy nor the quality of pre-
ESRD care can significantly account for the failure of the
health care providers to offer chronic peritoneal dialysis
to their patients. At least several additional reasons could
be considered in future studies. First, physicians may be
biased against chronic peritoneal dialysis or believe that
chronic peritoneal dialysis is associated with poorer out-
comes. However, registry comparisons of incident ESRD
patients suggest that chronic peritoneal dialysis therapy
is associated with an early survival advantage in most pa-
tient subgroups [22–25]. Moreover, there is little evidence
to suggest bias against chronic peritoneal dialysis among
United States nephrologists. In a recent survey, nephrol-
ogists indicated that in order to promote survival, well-
ness, quality of life and cost-effectiveness, home dialysis
therapies should be utilized by 45% to 56% of ESRD pa-
tients [9]. Second, some patients may have sociocultural
contraindications to home dialysis therapy. However, a
recent study from The Netherlands suggests that only an
additional 10% of patients may have social contraindi-
cations to chronic peritoneal dialysis. The prevalence in
the United States remains uncertain [21]. Third, the in-
frastructure for chronic peritoneal dialysis is available in
less than one half of the dialysis units and may limit the
access of patients to these therapies. This limitation is un-
likely to be operative in our study since most patients in
ESRD Network 18 live in densely populated urban areas.
Most patients in ESRD Network 18 also are close enough
to dialysis units such that distance from dialysis unit is
probably not as important a consideration as has been
reported from recent studies [6, 7, 20]. Fourth, physicians
may not have been adequately trained in caring for home
dialysis patients and thus, may feel uncomfortable in of-
fering chronic peritoneal dialysis to their patients [26].
Finally, pre-ESRD education is not reimbursable and fi-
nancial constraints on practices may limit their ability to
provide either the time or resources to optimally educate
the patients regarding RRT.
Another novel finding of this study is the demon-
stration of the importance of pre-ESRD education (the
probability of being offered chronic peritoneal dialysis
and the amount of time spent in modality education)
in the selection of the dialysis modality. Several studies
have reported the clinical, demographic and pre-ESRD
care variables associated with modality selection [6, 7,
20, 21]. Several others have reported the relationship
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between delayed referral to a nephrologist and the un-
derutilization of chronic peritoneal dialysis [7, 27]. In
this study, we identified some of the same characteris-
tics associated with a higher probability of selection of
chronic peritoneal dialysis: young age, employment sta-
tus, longer period of knowledge about kidney failure, and
higher predialysis plasma hemoglobin and serum albumin
levels. However, consistent with the findings from New
Jersey, we were unable to demonstrate an indepen-
dent relationship between the duration of predialysis
nephrologic care and the selection of chronic peritoneal
dialysis [28]. Moreover, none of the earlier studies di-
rectly addressed the contribution of the probability of
chronic peritoneal dialysis being offered as an option
for treatment or the amount of time spent in pre-ESRD
education to modality selection. Our study raises the
possibility that an important reason why several clini-
cal, demographic or pre-ESRD variables (like the timing
of referral to a nephrologist) are associated with selec-
tion of chronic peritoneal dialysis is because physicians
are more likely to present chronic peritoneal dialysis to
these groups of patients. Indeed, if the patients are not
made aware that there are alternatives to maintenance
hemodialysis, they are unlikely to choose home dialysis
modalities.
There are significant moral/ethical, economic, and reg-
ulatory implications of our findings. In the absence of
compelling medical or sociocultural contraindications to
one form of RRT, an incomplete presentation of treat-
ment options cannot be morally/ethically justified. Con-
sistent with our findings, several lines of evidence sug-
gest that patients value the information and the right
to choose a dialysis modality. In a recently reported
study from The Netherlands, 773 incident patients under-
went the usual process of education regarding options for
RRT. They were then offered the choice to be random-
ized to treatment with either maintenance hemodialysis
or chronic peritoneal dialysis and 735 (95%) refused to
be randomized since they wanted to choose their dial-
ysis modality [29]. Indeed, patients undergoing mainte-
nance hemodialysis cite the limited amount of informa-
tion provided to them regarding home therapies as one
of the most important reason for not choosing chronic
peritoneal dialysis or home hemodialysis [12] and com-
prehensive patient education programs are associated
with a substantially higher selection of home dialysis [14,
20, 30, 31] [abstract; Golper et al, J Am Soc Nephrol
11:231A, 2000). Consistent with these observations, more
patients beginning chronic peritoneal dialysis treatment
rate their dialysis care as excellent compared to patients
beginning maintenance hemodialysis; an important rea-
son for this difference relates to domains of pre-ESRD
education [32]. Finally, the strength of patients’ pref-
erence for a dialysis modality cannot be predicted by
their clinical characteristics [33]. All these considerations
make a complete and balanced presentation of treat-
ment options, imperative to the care of all incident ESRD
patients.
The costs to the Medicare system for patients under-
going home dialysis therapies are consistently lower than
those for patients undergoing maintenance hemodialysis.
It is probably for this reason that CMS provided reim-
bursement incentives to promote a greater utilization of
chronic peritoneal dialysis and home hemodialysis. Con-
sequently, the ESRD Networks and the Medical Direc-
tors of dialysis units have been charged with ensuring
that patients are offered appropriate choices for RRT.
Our study suggests that the current regulatory environ-
ment does not ensure an equal access to all RRTs to most
patients. Furthermore, there are significant financial im-
plications of the under use of home dialysis. In 2001, only
8.8% of the 292,215 patients undergoing maintenance
dialysis in the United States utilized home dialysis. In the
period 1997 to 2001, the annual Medicare per capita pay-
ments for patients undergoing maintenance hemodialysis
were $53,100 as compared to $41,342 for chronic peri-
toneal dialysis patients. Thus, doubling of the utilization
of chronic peritoneal dialysis could save CMS over $300
million/year.
Our study design also raises concern that an early ac-
cess to transplantation is probably unavailable to most in-
cident ESRD patients. Thus, provider factors appear to be
as important in determining access to transplantation in
the predialysis phase as have been reported after the com-
mencement of maintenance dialysis [34]. Unlike previous
single-center reports, this study from a large geographic
area was unable to demonstrate any relationship between
the duration of predialysis nephrologic care and an early
discussion of transplantation [35]. It is possible that most
nephrology providers defer the discussion of transplanta-
tion to after the commencement of maintenance dialysis.
However, the inability to discuss the option of transplan-
tation at the time of initial discussion of treatment options
would almost entirely exclude the possibility of preemp-
tive transplantation, an option associated with superior
outcomes [2–4]. Furthermore, it eliminates the possibility
of preemptive listing for a cadaveric transplantation. This
would inevitably lead to longer waiting times on mainte-
nance dialysis and, since graft outcome is inversely re-
lated to dialysis vintage, this policy is not expected to be
associated with the best outcomes.
It follows then that improvements in pre-ESRD educa-
tion can potentially increase the utilization of home dial-
ysis, result in an earlier evaluation for transplantation and
increase the rates of preemptive transplantation. These,
in turn, are likely to improve patient outcomes along with
significant savings to the Medicare system. Thus, it is crit-
ical that third party payers like CMS provide consistent
and appropriate reimbursement for pre-ESRD educa-
tion.
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There are several limitations of this study. First, 31% of
the incident patients responded to the survey. However,
the commencement of maintenance dialysis is a major,
life-altering event in a patient’s life. A voluntary par-
ticipation and an independent response by the patients
were crucial to the validity of this study. Not withstand-
ing the low response rate, our findings merit consideration
for possibly a more detailed study. Second, our inability
to demonstrate the relationship between variables like
age and employment status to the selection of chronic
peritoneal dialysis may be related to sample size of the
respondents. Despite this limitation, the key findings of
the importance of pre-ESRD education remain robust.
Third, the study was limited to only one of the 18 ESRD
Networks. Despite the unique demographics of our pop-
ulation, these data are consistent with those from the
DMMS Wave 2 Study. Fourth, the cross-sectional nature
of the study limits our ability to conclude that any of these
associations are indeed causal. Fifth, given the relatively
small period of observation, we were unable to adjust
for the center effect. Finally, recall bias may have led us
to overestimate the lack of pre-ESRD education. Med-
ical records in dialysis units often have limited, if any,
information on pre-ESRD care and review of medical
records would not have overcome this problem. How-
ever, our study design allows to us to estimate “effective
education,” a more relevant measure of the adequacy of
education.
CONCLUSION
This study suggests that an important reason for the
relatively low utilization of home dialysis therapies in the
United States arises from the inability of providers to
present chronic peritoneal dialysis or home hemodialy-
sis as alternatives to in-center hemodialysis or to spend
enough time in explaining the treatment options to inci-
dent ESRD patients. Moreover, since transplantation is
not offered as a method of treatment to most patients be-
ginning chronic dialysis, access to transplantation is prob-
ably delayed. These results provide support for the need
to provide pre-ESRD patient education to optimize the
utilization of home dialysis therapies and provide an ear-
lier access to transplantation. Consistent and appropriate
reimbursement for pre-ESRD education is likely to im-
prove the access of patients in the United States to the
various modalities for RRT.
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